The expanding role of metformin: From COVID-19 outcomes to healthy aging management?

The expanding role of metformin: From COVID-19 outcomes to healthy aging management?

Authors

  • Giovanni Cangelosi University of Camerino
  • Fabio Petrelli University of Camerino

Keywords:

None

Abstract

None

References

Petrelli F, Grappasonni I, Nguyen CTT, Tesauro M, Pantanetti P, Xhafa S, et al. Metformin and Covid-19: a systematic review of systematic reviews with meta-analysis. Acta Biomed. 2023 Aug 30;94(S3):e2023138. doi: 10.23750/abm.v94iS3.14405.

Gnesin F, Thuesen ACB, Kähler LKA, Madsbad S, Hemmingsen B. Metformin monotherapy for adults with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2020 Jun 5;6(6):CD012906. doi: 10.1002/14651858. CD012906.pub2.

Zhou T, Yu Y, Li L, Liu X, Xiang Q, Yu R. Bibliometric analysis of metformin as an immunomodulator (2013-2024). Front Immunol. 2025 Jan 8;15:1526481. doi: 10.3389/fimmu.2024.1526481.

Triggle CR, Mohammed I, Bshesh K, Marei I, Ye K, Ding H, MacDonald R, Hollenberg MD, Hill MA. Metformin: Is it a drug for all reasons and diseases? Metabolism. 2022 Aug;133:155223. doi: 10.1016/j.metabol.2022.155223.

Alshahrani O, Almalki MS. The Efficacy of Pharmacotherapy in the Treatment of Obesity in Patients With Type 2 Diabetes: A Systematic Review. Cureus. 2024 Jul 24;16(7):e65242. doi: 10.7759/cureus.65242.

Cangelosi G, Mancin S, Pantanetti P, Nguyen CTT, Morales Palomares S, Biondini F, et al. Lifestyle Medicine Case Manager Nurses for Type Two Diabetes Patients: An Overview of a Job Description Framework—A Narrative Review. Diabetology. 2024, 5, 375–388. doi.org/10.3390/diabetology5040029.

Downloads

Published

24-04-2025

Issue

Section

LETTERS TO THE EDITOR AND CORRESPONDENCE

How to Cite

1.
Cangelosi G, Petrelli F. The expanding role of metformin: From COVID-19 outcomes to healthy aging management?. Acta Biomed. 2025;96(2):16897. doi:10.23750/abm.v96i2.16897